Union Korea Pharm (KOSDAQ:A080720) appointed Sung Kwang-hyun as its new chief executive officer, effective the same day, according to a Tuesday filing with the Korean Exchange.
Kwang-hyun will succeed Jung Geun-ho, who will step down as part of the court-approved rehabilitation plan.